Detection of Antibodies to Gangliosides in Pathologic Human Sera. Serum-Sickness Type Heterophile Antibodies
The production of heterophile antibodies in sera of patients receiving therapeutic injections of foreign serum was first described by HANGANUTIZIU (1924) and DEICHER (1926). Thereafter, these antibodies were called serum-sickness or H-D antibodies. The antibodies differ in specificity from other kinds of heterophile antibodies, such as FORSSMAN (1911) antibodies and PAUL-BUNNELL (1932) antibodies (P-B antibodies) of infectious mononucleosis. H-D antibodies react with erythrocytes and sera of various animal species (horse, sheep, ox and rabbit) and are absorbed by sediment of guinea-pig kidney homogenate (DAVIDSON and WALKER, 1935). Recently, “H-D antibodies” were detected in sera from almost of all patients who received γ-globulin fraction of goat anti-human thymocyte serum (PIROFSKY, RAMIREZ-MATEOS and AUGUST (1973) and also in sera from some patients, suffering from various diseases, who had never received a therapeutic injection of foreign serum (KASUKAWA et al., 1976). The nature of H-D antigen was unknown, except for some properties: heat-stable, extractable with hot ethanol (SCHIFF, 1937) and precipitable by 75% ethanol solution (KASUKAWA et al., 1976). Our previous studies (HIGASHI et al., 1977) succeeded in the isolation of H-D antigen from bovine and equine erythrocytes and demonstrated that this antigen is a ganglioside with N-glycolylneuraminic acid (GcNeu). The antigen of equine erythrocytes was identified as GcNeu-hematoside (YAMAKAWA and SUZUKI, 1951), and the antigen of bovine erythrocytes was identified as GcNeu-sialosylparagloboside (WIEGANDT and SCHULZE, 1969). The structures of both the gangliosides are shown in Table 1.
KeywordsSialic Acid Infectious Mononucleosis Complement Fixation Bovine Erythrocyte Therapeutic Injection
Unable to display preview. Download preview PDF.
- DAVIDSON I. and WALKER P.H. (1935): The nature of heterophile antibodies in infectious mononucleosis. Amer. J. clin. Path. 5, 455–465.Google Scholar
- FORSSMAN J. (1911): Die Herstellung hochwertiger spezifischer Schaf- hämolysine ohne Verwendung von Schafblut. Biochem. Z. 37, 78–115.Google Scholar
- GOTTSCHALK A. (1972): Glycoproteins, their composition, structure and function. Elsevier Publishing Co. ( Amsterdam).Google Scholar
- HANGANUTZIU M. (1924): Hémagglutinines hétérogénétiques après injection de sérum de cheval. C. R. Soc. Biol. 91, 1457–1459.Google Scholar
- PIROFSKY B., RAMIREZ-MATEOS L.C. and AUGUST A. (1973): “Foreign serum” heterophile antibodies in patients receiving antithymocyte antisera. Blood 42, 385–393.Google Scholar
- SCHIFF F. (1937): Heterogenetic hemagglutinins in man following the therapeutic injections of immune sera produced in rabbits. J. Immun. 33, 305–313.Google Scholar
- TAKETOMI T., HARA A. and UEMURA K. (1975): Immunological studies of lipids. IV. Chemical modification of Forssman globoside and immunological activity. Jap. J. Med. 45, 293–298.Google Scholar
- WIEGANDT H. and SCHULZE B. (1969): Spleen gangliosides: the structure of ganglioside GLNnT1 (NGNA). Z. Naturforschg. 24b, 945–946.Google Scholar
- YAMAKAWA T. and SUZUKI S. (1951): The chemistry of the lipids of posthemolytic residue or stroma of erythrocytes. I. Concerning the ether-insoluble lipids of lyophilized horse blood stroma. J. Biochem. 38, 199–212.Google Scholar